Spruce Biosciences

Spruce Biosciences: Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. Spruce is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy for patients suffering from classic congenital adrenal hyperplasia (CAH). Classic CAH is a serious and life-threatening disease with no known novel therapies approved in approximately 50 years. Spruce is also developing tildacerfont for women suffering from a rare form of polycystic ovary syndrome (PCOS) with primary adrenal androgen excess.
Based in...
US - Pacific
Clinical Stage
Phase III, Phase l or ll
Disease Space
Metabolic Disorders, Rare Disease
Public, USA
Market Cap
611 Gateway Boulevard, Suite 740
South San Francisco, CA 94080
United States

Company Participants at Solebury 1x1 Management Access Event 2023

  • Javier Szwarcberg, CEO

Upcoming Company Event Participation

Top 10 Holders of Spruce Biosciences, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Novo Holdings A/S 19.16 4,514,336 4.92 13F 9/30/22
Omega Fund Management LLC 9.17 2,161,022 2.36 13F 9/30/22
RiverVest Venture Management LLC 9.12 2,148,281 2.34 13F 9/30/22
Abingworth LLP 7.61 1,792,518 1.95 13F 9/30/22
Citadel Advisors LLC (13f Subfiler) 7.21 1,698,618 1.85 13F 9/30/22
Rock Springs Capital Management LP 6.89 1,622,689 1.77 13F 9/30/22
Aisling Capital Management LP 5.12 1,205,511 1.31 13F 9/30/22
Logos Global Management LP 4.24 1,000,000 1.09 13F 9/30/22
Sands Capital Ventures LLC 3.34 787,007 0.86 13F 9/30/22
Millennium Management LLC 0.62 145,015 0.16 13F 9/30/22
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2022 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.